PITTSBURGH (AP) — PITTSBURGH (AP) — NeuBase Therapeutics, Inc. (NBSE) on Tuesday reported a loss of $4.4 million in its fiscal first quarter.

The Pittsburgh-based company said it had a loss of 13 cents per share.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBSE at https://www.zacks.com/ap/NBSE

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights., source Associated Press News